Jaime Lawson
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jaime Lawson has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Jonathan Williams
ConvergenceLabs@VCU—Health Outcomes Virginia Commonwealth University Richmond Virginia USA
2 shared publications - Katherine Falls
ConvergenceLabs@VCU—Health Outcomes Virginia Commonwealth University Richmond Virginia USA
2 shared publications - Natalie Mansion
School of Nursing, Virginia Commonwealth University, Richmond, VA, United States
2 shared publications - Rachel A. Regal
Virginia Commonwealth University, Richmond, VA, USA
2 shared publications - Ana F. Diallo
ConvergenceLabs@VCU—Health Outcomes Virginia Commonwealth University Richmond Virginia USA
1 shared publication - Elvin Price
Department of Pharmacotherapy and Outcomes Science, School of Pharmacy Virginia Commonwealth University Richmond Virginia USA
1 shared publication
Latest Publications
- Open Access
- 5 May 2026
- Published by JMIR Publications Inc. in JMIR Preprints
Understanding Challenges of Remote Health Technology Use: A Pre-implementation Assessment among Community Health Stakeholders (Preprint)
BACKGROUND The COVID-19 pandemic accelerated telehealth adoption, particularly for older adults, yet end-user non-acceptance of digital health tools remains a persistent barrier. This evaluation engaged the Mobile Health and Wellness Program (MHWP), a nurse-led mobile clinic serving urban-dwelling older adults with chronic conditions, to implement Health Recovery Solutions (HRS) Remote Patient Monitoring (RPM) devices to extend its reach and boost health equity. OBJECTIVE This pre-implementation research project aimed to identify the strongest predictors of the intention to use technology among MHWP care delivery providers and participants. Using the constructs from the Technology Acceptance Model (TAM) to inform implementation of HRS RPM devices within MHWP. METHODS Two cross-sectional surveys were administered to MHWP providers (n = 31) and participants (n = 18). Reliability of the constructs was assessed via Cronbach’s α, and multiple linear and ridge regression models were fit to predict Behavioral Intention (IN). Analyses were exploratory given the small sample sizes and should be interpreted as hypothesis-generating. RESULTS For MHWP providers, the model explain 70% of variance in intention to use telemonitoring (R2 = .697, P < .001), with Perceived Usefulness (PU) and Perceived Ease of Use (PEU) as the strongest predictors of IN. For MHWP participants, the model was not statistically significant (R2 = .527, P = .24), with Availability emerging as the most influential construct in exploratory ridge regression. CONCLUSIONS Provider-focused implementation should prioritize demonstrating practical benefits and ensuring user-friendly operation. For participants, unobstructed access to telehealth technology appears most critical for fostering adoption intent. These cross-stakeholder findings offer preliminary exploratory insights to guide equitable RPM implementation in community-based care. CLINICALTRIAL N/A
- 5 May 2026
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessUnderstanding Challenges of Remote Health Technology Use: A Pre-implementation Assessment among Community Health Stakeholders (Preprint)
BACKGROUND The COVID-19 pandemic accelerated telehealth adoption, particularly for older adults, yet end-user non-acceptance of digital health tools remains a persistent barrier. This evaluation engaged the Mobile Health and Wellness Program (MHWP), a nurse-led mobile clinic serving urban-dwelling older adults with chronic conditions, to implement Health Recovery Solutions (HRS) Remote Patient Monitoring (RPM) devices to extend its reach and boost health equity. OBJECTIVE This pre-implementation research project aimed to identify the strongest predictors of the intention to use technology among MHWP care delivery providers and participants. Using the constructs from the Technology Acceptance Model (TAM) to inform implementation of HRS RPM devices within MHWP. METHODS Two cross-sectional surveys were administered to MHWP providers (n = 31) and participants (n = 18). Reliability of the constructs was assessed via Cronbach’s α, and multiple linear and ridge regression models were fit to predict Behavioral Intention (IN). Analyses were exploratory given the small sample sizes and should be interpreted as hypothesis-generating. RESULTS For MHWP providers, the model explain 70% of variance in intention to use telemonitoring (R2 = .697, P < .001), with Perceived Usefulness (PU) and Perceived Ease of Use (PEU) as the strongest predictors of IN. For MHWP participants, the model was not statistically significant (R2 = .527, P = .24), with Availability emerging as the most influential construct in exploratory ridge regression. CONCLUSIONS Provider-focused implementation should prioritize demonstrating practical benefits and ensuring user-friendly operation. For participants, unobstructed access to telehealth technology appears most critical for fostering adoption intent. These cross-stakeholder findings offer preliminary exploratory insights to guide equitable RPM implementation in community-based care. CLINICALTRIAL N/A
- Open Access
- 31 October 2025
- Published by Wiley in Clinical and Translational Science
- Vol. 18 (11) , e70385
Informing Inclusive Engagement in Clinical Research: Insights From a Long‐Standing Community‐Based Wellness and Prescription Produce Program
The lack of diversity in clinical trials and drug development negatively impacts public health. Growing evidence suggests that successful recruitment, retention, and protocol compliance, such as medication adherence, must account for social drivers of health, particularly among underrepresented populations. Implementing novel approaches, such as the wellness and prescription produce program described in this perspective, may bring research to communities in ways that facilitate meaningful inclusion of underrepresented populations in clinical trials and promote health equity.
- 31 October 2025
- Published by Wiley in Clinical and Translational Science
- Vol. 18 (11) , e70385
Open AccessInforming Inclusive Engagement in Clinical Research: Insights From a Long‐Standing Community‐Based Wellness and Prescription Produce Program
The lack of diversity in clinical trials and drug development negatively impacts public health. Growing evidence suggests that successful recruitment, retention, and protocol compliance, such as medication adherence, must account for social drivers of health, particularly among underrepresented populations. Implementing novel approaches, such as the wellness and prescription produce program described in this perspective, may bring research to communities in ways that facilitate meaningful inclusion of underrepresented populations in clinical trials and promote health equity.